Telemedicine-Enhanced Lung Cancer Screening Using Mobile Computed Tomography Unit with Remote Artificial Intelligence Assistance in Underserved Communities: Initial Results of a Population Cohort Study in Western China
Authors:
Open Access
- 21 June 2024
- journal article
- research article
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 30 (6) , e1695-e1704
Abstract
Introduction: Lung cancer is a leading cause of cancer deaths globally. Despite favorable recommendations, low-dose computed tomography (LDCT) lung screening adoption remains low in China. Barriers such as limited infrastructure, costs, distance, and personnel shortages restrict screening access in disadvantaged regions. We initiated a telemedicine-enabled lung cancer screening (LCS) program in a medical consortium to serve people at risk in underserved communities. The objective of this study was to describe the implementation and initial results of the program. Methods: From 2020 to 2021, individuals aged 40–80 years were invited to take LCS by mobile computed tomography (CT) units in three underserved areas in Western China. Numerous CT scans were remotely reported by radiologists aided by artificial intelligence (AI) diagnostic systems. Abnormal cases were tracked through an integrated hospital network for follow-up. A retrospective cohort study documented participant demographics, health history, LDCT results, and outcomes. Descriptive analysis was conducted to report baseline characteristics and first-year follow-up results. Results: Of the 28,728 individuals registered in the program, 19,517 (67.94%) participated in the screening. The study identified 2.68% of participants with high-risk pulmonary nodules and diagnosed 0.55% with lung cancer after a 1-year follow-up. The majority of high-risk participants received timely treatment in hospitals. Conclusions: This study demonstrated mobile CT units with remote AI assistance improved access to LCS in underserved areas, with high participation and early detection rates. Our implementation supports the feasibility of deploying telemedicine-enabled LCS to increase access to a large scale of basic radiology and diagnostic services in resource-limited settings. Clinical Trial Registration Number: ChiCTR1900024623: .Keywords
This publication has 21 references indexed in Scilit:
- The Pathway of China’s Integrated Delivery System: Based on the Analysis of the Medical Consortium PoliciesCurrent Medical Science, 2022
- Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016Journal of the National Cancer Center, 2022
- Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based studyeClinicalMedicine, 2022
- Screening for Lung Cancer With Low-Dose Computed TomographyJAMA, 2021
- Performance of low-dose computed tomography on lung cancer screening in high-risk populations: The experience over five screening rounds in Sichuan, ChinaCancer Epidemiology, 2020
- The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countriesNature Cancer, 2020
- Mobile Lung Screening: Should We All Get on the Bus?The Annals of Thoracic Surgery, 2020
- Poor Uptake of Lung Cancer Screening: Opportunities for ImprovementJournal of the American College of Radiology, 2019
- Implementing a mobile diagnostic unit to increase access to imaging and laboratory services in western KenyaBMJ Global Health, 2018
- Challenges to effective cancer control in China, India, and RussiaThe Lancet Oncology, 2014